TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00815516

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“It was decided to discontinue the study due to insufficient recruitment.”

The sponsor’s own words in the registry.

Life of this trial

200820092010201120122013201420152016Registered2008-12-27Started2013-02Stopped2014-12Results posted2015-09-15

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Astellas Pharma Global Development, Inc.
Sponsor type
Industry
Conditions
Candidiasis
Interventions
micafungin; amphotericin B deoxycholate
Participants
30
Sites
17
Countries
Brazil, Bulgaria, Canada, Colombia, Greece, Hungary, Israel, Philippines, Romania, Turkey (Türkiye), Ukraine, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.